[1] World Health Organization. Infant and Young Child Nutrition： Global Strategy on Infant and Young Child Feeding (Report A55/15) [C]. Geneva：WHO；2002.
[2] Shah NP. Effects of milk-derived bioactives：an overview [J]. Br J Nutr 2000，84 (Suppl 1)：S3-S10.
[3] Jinsmaa Y，Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein [J]. Peptides ，1999，20(8)：957-962.
[4] Koch G，Wiedemann K，Teschemacher H. Opioid activities of human beta-casomorphins [J]. Naunyn Schmiedebergs Arch Pharmacol，1985，331(4)：351-354.
[5] Monetini L，Cavallo MG, Stefanini L，et al. Bovine beta-casein antibodies in breast- and bottle-fed infants：their relevance in Type 1 diabetes [J]. Diabetes Metab Res Rev，2001，17(1)：51-54.
[6] Sun Z，Zhang Z，Wang X, et al. Relation of beta-casomorphin to apnea in sudden infant death syndrome [J]. Peptides，2003，24(6)：937-943.
[7] Pasi A，Mahler H，Lansel N，et al. Beta-Casomorphin-immunoreactivity in the brain stem of the human infant [J]. Res Commun Chem Pathol Pharmacol，1993，80(3)：305-322.
[8] Andiran F，Dayi S，Mete E. Cows' milk consumption in constipation and anal fissure in infants and young children [J]. J Paediatr Child Health，2003，39(5)：329-331.
[9] Chen W，Chung HH，Cheng JT. Opiate-induced constipation related to activation of small intestine opioid mu2-receptors [J]. World J Gastroenterol，2012，18(12)：1391-1396.
[10] Daher S，Tahan S，Sole D，et al. Cow's milk protein intolerance and chronic constipation in children [J]. Pediatr Allergy Immunol，2001，12(6)：339-342.
[11] Hamosh M. Digestion in the newborn [J]. Clin Perinatol，1996，23(2)：191-209.
[12] Weaver LT. Breast and gut：the relationship between lactating mammary function andneonatal gastrointestinal function [J]. Proc Nutr Soc ，1992，51(2)：155-163.
[13] Walker WA. Absorption of protein and protein fragments in the developing intestine：role in immunologic/allergic reactions [J]. Pediatrics，1985，75(1pt2)：167-171.
[14] Migliore-Samour D， Floc’h F， Jollès P. Biologically active casein peptides implicated in immunomodulation [J]. J Dairy Res，1989，56(3)：357-362.
[15] Migliore-Samour D，Jollès P. Casein，a prohormone with an immunomodulating role for the newborn? [J]. Experientia，1988，44(3)：188-193.
[16] Kurek M，Przybilla B，Hermann K，et al. A naturally occurring opioid peptide from cow’s milk，beta-casomorphine-7，is a direct histamine releaser in man [J]. Int Arch Allergy Immunol，1992，97(2)：115-120.
[17] St?pnika M, Kurekb M. The influence of bovine casein-derived exorphins on mast cells in rodents [J]. Revue Fran?aise d'Allergologie et d'Immunologie Clinique, 2002, 42(5)：447-453.
[18] Elitsur Y，Luk GD. Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation [J]. Clin Exp Immunol，1991，85(3)：493-497.
[19] Kayser H，Meisel H. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins [J]. FEBS Lett，1996，383(1-2)：18-20.
[20] Kurek M，Czerwionka-Szaflarska M，Doroszewska G. Pseudoallergic skin reactions to opiate sequences of bovine casein in healthy children [J]. Rocz Akad Med Bialymst，1995，40(3)：480-485.
[21] Roy S，Wang J，Kelschenbach J，et al. Modulation of immune function by morphine：implications for susceptibility to infection [J]. J Neuroimmune Pharmacol，2006，1(1)：77-89.
[22] Patterson CC，Dahlquist GG，Gyurus E，et al. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20：a multicentre prospective registration study [J]. Lancet，2009，373(9680)：2027-2033.
[23] Diamond Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999 [J]. Diabet Med，2006，23(8)：857-866.
[24] Akerblom HK，Knip M. Putative environmental factors in Type 1 diabetes [J]. Diabetes Metab Rev，1998，14(1)：31-67.
[25] Elliott RB，Martin JM. Dietary protein：a trigger of insulin-dependent diabetes in the BB rat? [J]. Diabetologia,1984,26(4)：297-299.
[26] Scott F.W. Cow milk and insulin-dependent diabetes mellitus：is there a relationship? [J]. Am J Clin Nutr，1990，51(3)：489-491.
[27] Gerstein HC. Cows' milk exposure and type I diabetes mellitus. A cri-tical overview of the clinical literature [J]. Diabetes Care，1994，17(1)：13-19.
[28] Fava D，Leslie RD，Pozzilli P. Relationship between dairy product consumption and incidence of IDDM in childhood in Italy [J]. Diabetes Care，1994，17(12)：1488-1490.
[29] Saukkonen T，Savilahti E，Landin-Olsson M，et al. IgA bovine serum albumin antibodies are increased in newly diagnosed patients with insulin-dependent diabetes mellitus，but the increase is not an independent risk factor for diabetes [J]. Acta Paediatr，1995，84(11)：1258-1261.
[30] Virtanen SM，Hypponen E，Laara E，et al. Cow’s milk consumption，disease-associated autoantibodies and type 1 diabetes mellitus：a follow-up study in siblings of diabetic children. Childhood Diabetes in Finland Study Group [J]. Diabet Med，1998，15(9)：730-738.
[31] Bodington MJ，McNally PG，Burden AC. Cow's milk and type 1 childhood diabetes：no increase in risk [J]. Diabet Med,1994,11(7)：663-665.
[32] Couper JJ，Steele C，Beresford S, et al. Lack of association between duration of breastfeeding or introduction of cow's milk and development of islet autoimmunity [J]. Diabetes, 1999,48(11)：2145-2149.
[33] Luhder F，Schlosser M，Michaelis D, et al. No association between anti-bovine serum albumin antibodies and islet cell reactive antibodies in newly diagnosed type 1 diabetic patients [J]. Diabetes Res ClinPract, 1994,26(1)：35-41.
[34] Elliott RB，Harris DP，Hill JP, et al. Type I (insulin-dependent) diabetes mellitus and cow milk：casein variant consumption [J]. Diabetologia, 1999;42(3)：292-296.
[35] Laugesen M，Elliott R. Ischaemic heart disease，type 1 diabetes，and cow milk A1 beta-casein [J]. N Z Med J, 2003,116(1168)：u295.
[36] McLachlan CN. Beta-casein A1，ischaemic heart disease mortality，and other illnesses [J]. Med Hypotheses, 2001,56(2)：262-272.
[37] Birgisdottir BE，Hill JP，Thorsson AV，et al. Lower consumption of cow milk protein A1 beta-casein at two years of age，rather than consumption among 11- to 14-year-old adolescents，may explain the lower incidence of type 1 diabetes in Iceland than in Scandinavia [J]. Ann Nutr Metab,2006,50(3)：177-183.
[38] Wasilewska J，Sienkiewicz-Szlapka E，Kuzbida E, et al. The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE) [J]. Neuropeptides,2011,45(3)：189-195.
[39] Sankaran K， Hindmarsh KW，Wallace SM. Cerebrospinal fluid and plasma beta-endorphin concentrations in prolonged infant apnea (near-miss sudden infant death syndrome) [J]. Dev Pharmacol Ther，1986，9：224-230.
[40] Storm H，Reichelt CL，Rognum TO. Beta-endorphin，human caseomorphin and bovine caseomorphinimmunoreactivity in CSF in sudden infant death syndrome and controls [J]. ProgClinBiol Res, 1990,328：327-330.
[41] Wasilewska J，Kaczmarski M，Kostyra E，et al. Cow's-milk-induced infant apnoea with increased serum content of bovine beta-casomorphin-5 [J]. J Pediatr Gastroenterol Nutr, 2011,52(6)：772-775.
[42] Hedner J，Hedner T. Beta-casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits [J]. Life Sci,1987,41(20)：2303-2312. |
